BGI Genomics Co (SZSE:300676) Change In Inventory : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BGI Genomics Co Change In Inventory?

BGI Genomics Co's change in inventory for the quarter that ended in Mar. 2024 was ¥0 Mil. It means BGI Genomics Co's inventory stayed the same from Dec. 2023 to Mar. 2024 .

BGI Genomics Co's change in inventory for the fiscal year that ended in Dec. 2023 was ¥104 Mil. It means BGI Genomics Co's inventory declined by ¥104 Mil from Dec. 2022 to Dec. 2023 .

BGI Genomics Co's Total Inventories for the quarter that ended in Mar. 2024 was ¥593 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. BGI Genomics Co's Days Inventory for the quarter that ended in Mar. 2024 was 130.74.

Inventory Turnover measures how fast the company turns over its inventory within a year. BGI Genomics Co's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.70.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. BGI Genomics Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.73.

BGI Genomics Co Change In Inventory Historical Data

The historical data trend for BGI Genomics Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BGI Genomics Co Change In Inventory Chart

BGI Genomics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-101.07

-603.70

169.94

46.26

103.78

BGI Genomics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

BGI Genomics Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

BGI Genomics Co (SZSE:300676) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

BGI Genomics Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	597.8175	/	417.234	*	365 / 4
	=	130.74

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

BGI Genomics Co's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	417.234	/	597.8175
	=	0.70

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

BGI Genomics Co's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	597.8175	/	821.25
	=	0.73

BGI Genomics Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of BGI Genomics Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

BGI Genomics Co (SZSE:300676) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BGI Genomics Co Ltd (SZSE:300676) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

21 Hongan Third Street, Dong, Huada Complex Park, Yantian District, Shenzhen, CHN, 518083

Website

http://www.bgi.com

BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.

Executives

Wang Jian	Director
Liu Na	Executives
Sun Ying Jun	Director
Yin Ye	Directors, executives
Du Yu Tao	Directors, executives
Li Song Gang	Supervisors
Hu Yu Jie	Supervisors
Xu Qian	Secretary Dong
Li Zhi Ping	Executives
Chen Yi Qing	Executives
Li Wen Qi	Supervisors

BGI Genomics Co (SZSE:300676) Headlines

No Headlines